Lessee, Operating Lease, Liability, to be Paid in USD of Can-Fite BioPharma Ltd. from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q4 2019 to Q4 2024.
  • Can-Fite BioPharma Ltd. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $133K, a 217% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $133K +$91K +217% 31 Dec 2024 20-F 14 Apr 2025
Q4 2023 $42K 31 Dec 2023 20-F 28 Mar 2024
Q4 2019 $82K 31 Dec 2019 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.